Rare diseases
Investigational molecules
Locations
Ul. Grunwaldzka 156, 60-309 Poznan, Poland
EMC Instytut Medyczny S.A. in Poznan, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Asthma, Dermatitis atopic, and other specialisations. This site conducts important research.
At EMC Instytut Medyczny S.A. in Poznan, clinical research in digestive system diseases is centered on ulcerative colitis. The trials are designed to evaluate whether new treatment options can improve symptom control and clinical response for people living with this chronic inflammatory condition.
This area of research helps determine how well emerging therapies may support patients with active ulcerative colitis and improve everyday disease management.
Clinical trials at this site also address respiratory tract diseases, with a focus on asthma. The research is evaluating whether combination inhaled treatments can provide better symptom relief and overall control for adolescents and adults affected by this common airway condition.
These studies contribute to understanding how new approaches may help people with asthma achieve more reliable symptom management and improved quality of life.
Clinical trials currently enrolling participants at this site.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
PolandPolandLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
PolandStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandA study testing duvakitug for patients with moderately to severely active ulcerative colitis
PolandPolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
